Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
Group Sign-on Letter to Congress Opposing the Preserving Employee Wellness Programs Act (HR 1313)
-
ACMG Comments to EEOC Concerning Proposed Rule Related to the Genetic Information Nondiscrimination Act (GINA)
-
ACMG Comments to OHRP Concerning Proposed Revisions to the Common Rule
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Comments to EEOC Concerning Regulations Under the Americans with Disabilities Act (ADA)
-
ACMG Applauds Supreme Court Decision on Gene Patents
-
ACMG Joins Amicus Brief in Mayo v. Prometheus to Counter Patents on Observations of Natural Phenomena
-
ACMG Comments to NIH about Development of the Genetic Test Registry